Authors:
PATEL N
SPANGLER EL
GREIG NH
YU QS
INGRAM DK
MEYER RC
Citation: N. Patel et al., PHENSERINE, A NOVEL ACETYLCHOLINESTERASE INHIBITOR, ATTENUATES IMPAIRED LEARNING OF RATS IN A 14-UNIT T-MAZE INDUCED BY BLOCKADE OF THE N-METHYL-D-ASPARTATE RECEPTOR, NeuroReport, 9(1), 1998, pp. 171-176
Citation: Qs. Yu et al., SYNTHESES AND ANTICHOLINESTERASE ACTIVITIES OF (3AS)-N-1,N-8-BISNORPHENSERINE, (3AS)-N-1,N-8-BISNORPHYSOSTIGMINE, THEIR ANTIPODAL ISOMERS, AND OTHER POTENTIAL METABOLITES OF PHENSERINE, Journal of medicinal chemistry, 41(13), 1998, pp. 2371-2379
Authors:
ALJAFARI AA
KAMAL MA
GREIG NH
ALHOMIDA AS
PERRY ER
Citation: Aa. Aljafari et al., KINETICS OF HUMAN ERYTHROCYTE ACETYLCHOLINESTERASE INHIBITION BY A NOVEL DERIVATIVE OF PHYSOSTIGMINE - PHENSERINE, Biochemical and biophysical research communications (Print), 248(1), 1998, pp. 180-185
Authors:
DEORE K
GREIG NH
HOLLOWAY HW
WANG YH
PERFETTI R
EGAN JM
Citation: K. Deore et al., THE EFFECTS OF GLP-1 ON INSULIN RELEASE IN YOUNG AND OLD RATS IN THE FASTING STATE AND DURING AN INTRAVENOUS GLUCOSE-TOLERANCE TEST, The journals of gerontology. Series A, Biological sciences and medical sciences, 52(5), 1997, pp. 245-249
Citation: Qs. Yu et al., TOTAL SYNTHESES AND ANTICHOLINESTERASE ACTIVITIES OF (3AS)-N(8)-NORPHYSOSTIGMINE, (3AS)-N(8)-NORPHENSERINE, THEIR ANTIPODAL ISOMERS, AND OTHER N(8)-SUBSTITUTED ANALOGS, Journal of medicinal chemistry, 40(18), 1997, pp. 2895-2901
Authors:
WANG YH
PERFETTI R
GREIG NH
HOLLOWAY HW
DEORE KA
MONTROSERAFIZADEH C
ELAHI D
EGAN JM
Citation: Yh. Wang et al., GLUCAGON-LIKE PEPTIDE-1 CAN REVERSE THE AGE-RELATED DECLINE IN GLUCOSE-TOLERANCE IN RATS, The Journal of clinical investigation, 99(12), 1997, pp. 2883-2889
Citation: B. Badio et al., PSEUDOPHRYNAMINOL - A POTENT NONCOMPETITIVE BLOCKER OF NICOTINIC RECEPTOR-CHANNELS, Biochemical pharmacology, 53(5), 1997, pp. 671-676
Citation: Dk. Lahiri et al., ANTICHOLINESTERASES, PHENSERINE, PHYSOSTIGMINE AND TACRINE - ON THE SECRETION OF BETA-AMYLOID PRECURSOR PROTEIN IN CELL-LINES, Molecular biology of the cell, 7, 1996, pp. 2851-2851
Authors:
ASTHANA S
GREIG NH
HOLLOWAY HW
RAFFAELE KC
BERARDI A
SCHAPIRO MB
RAPOPORT SI
SONCRANT TT
Citation: S. Asthana et al., CLINICAL PHARMACOKINETICS OF ARECOLINE IN SUBJECTS WITH ALZHEIMERS-DISEASE, Clinical pharmacology and therapeutics, 60(3), 1996, pp. 276-282
Citation: A. Brossi et al., INVITED REVIEW - PHENSERINE, A NOVEL ANTICHOLINESTERASE RELATED TO PHYSOSTIGMINE - TOTAL SYNTHESIS AND BIOLOGICAL PROPERTIES, Australian Journal of Chemistry, 49(2), 1996, pp. 171-181
Authors:
ASTHANA S
RAFFAELE KC
BERARDI A
GREIG NH
HAXBY JV
SCHAPIRO MB
SONCRANT TT
Citation: S. Asthana et al., TREATMENT OF ALZHEIMER-DISEASE BY CONTINUOUS INTRAVENOUS-INFUSION OF PHYSOSTIGMINE, Alzheimer disease and associated disorders, 9(4), 1995, pp. 223-232
Authors:
ASTHANA S
RAFFAELE KC
GREIG NH
BERARDI A
MORRIS PP
SCHAPIRO MB
RAPOPORT SI
BLACKMAN MR
SONCRANT TT
Citation: S. Asthana et al., NEUROENDOCRINE RESPONSES TO INTRAVENOUS-INFUSION OF ARECOLINE IN PATIENTS WITH ALZHEIMERS-DISEASE, Psychoneuroendocrinology, 20(6), 1995, pp. 623-636
Citation: Nh. Greig et al., PHENSERINE AND RING-C HETEROANALOGS - DRUG CANDIDATES FOR THE TREATMENT OF ALZHEIMERS-DISEASE, Medicinal research reviews, 15(1), 1995, pp. 3-31
Authors:
ASTHANA S
GREIG NH
HEGEDUS L
HOLLOWAY HH
RAFFAELE KC
SCHAPIRO MB
SONCRANT TT
Citation: S. Asthana et al., CLINICAL PHARMACOKINETICS OF PHYSOSTIGMINE IN PATIENTS WITH ALZHEIMERS-DISEASE, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 299-309
Authors:
NARIAI T
DEGEORGE JJ
GREIG NH
GENKA S
RAPOPORT SI
PURDON AD
Citation: T. Nariai et al., DIFFERENCES IN RATES OF INCORPORATION OF INTRAVENOUSLY INJECTED RADIOLABELED FATTY-ACIDS INTO PHOSPHOLIPIDS OF INTRACEREBRALLY IMPLANTED TUMOR AND BRAIN IN AWAKE RATS, Clinical & experimental metastasis, 12(3), 1994, pp. 213-225
Authors:
GREIG NH
BROSSI A
SONCRANT TT
HOLLOWAY HW
PEI XF
RAPOPORT SI
INGRAM DK
Citation: Nh. Greig et al., NOVEL, LONG-ACTING AND SELECTIVE PHYSOSTIGMINE ANALOGS AS POTENTIAL THERAPEUTICS FOR ALZHEIMERS-DISEASE, Journal of controlled release, 28(1-3), 1994, pp. 313-313
Authors:
INGRAM DK
SPANGLER EL
IIJIMA S
IKARI H
KUO H
GREIG NH
LONDON ED
Citation: Dk. Ingram et al., RODENT MODELS OF MEMORY DYSFUNCTION IN ALZHEIMERS-DISEASE AND NORMAL AGING - MOVING BEYOND THE CHOLINERGIC HYPOTHESIS, Life sciences, 55(25-26), 1994, pp. 2037-2049
Authors:
PEI XF
GREIG NH
FLIPPENANDERSON JL
BI S
BROSSI A
Citation: Xf. Pei et al., TOTAL SYNTHESIS OF RACEMIC AND OPTICALLY-ACTIVE COMPOUNDS RELATED TO PHYSOSTIGMINE AND RING-C HETEROANALOGUES FROM L]-2,3-DIHYDRO-5-METHOXY-1,3-DIMETHY-1H-INDOL-2-OL, Helvetica Chimica Acta, 77(5), 1994, pp. 1412-1422
Authors:
IIJIMA S
GREIG NH
GAROFALO P
SPANGLER EL
HELLER B
BROSSI A
INGRAM DK
Citation: S. Iijima et al., PHENSERINE - A PHYSOSTIGMINE DERIVATIVE THAT IS A LONG-ACTING INHIBITOR OF CHOLINESTERASE AND DEMONSTRATES A WIDE DOSE RANGE FOR ATTENUATING A SCOPOLAMINE-INDUCED LEARNING IMPAIRMENT OF RATS IN A 14-UNIT T-MAZE, Psychopharmacology, 112(4), 1993, pp. 415-420